Aveanna Healthcare (NASDAQ:AVAH) Insider Sells $575,000.00 in Stock

Key Points

• Insider sale: Aveanna Healthcare insider Edwin Reisz sold 50,000 shares at an average price of $11.50, generating $575,000. He retained 1,397,897 shares after the transaction, a 3.45% reduction in ownership.
• Strong financial results: The company reported quarterly earnings of $0.22 per share, exceeding estimates of $0.17, while revenue of $670.48 million also surpassed expectations.
• Positive analyst sentiment: Analysts have raised several price targets, and Aveanna carries a “Moderate Buy” consensus rating with an average target price of $12.89. The stock recently traded at $13.70, near its 52-week high of $13.98.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) insider Edwin Reisz sold 50,000 shares of the company's stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $575,000.00. Following the completion of the sale, the insider directly owned 1,397,897 shares of the company's stock, valued at approximately $16,075,815.50. This trade represents a 3.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Aveanna Healthcare Stock Performance

AVAH traded up $0.54 during trading on Monday, hitting $13.70. 5,364,375 shares of the stock were exchanged, compared to its average volume of 1,804,109. The firm has a market capitalization of $2.99 billion, a P/E ratio of 11.14, a PEG ratio of 0.92 and a beta of 1.90. Aveanna Healthcare Holdings Inc. has a 1-year low of $5.93 and a 1-year high of $13.98. The stock has a fifty day moving average price of $9.58 and a two-hundred day moving average price of $7.92. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.05. The business had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. As a group, sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on AVAH. Royal Bank Of Canada increased their target price on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the stock an "outperform" rating in a research note on Monday. Barclays lifted their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the company an "overweight" rating in a research note on Thursday, July 9th. Stephens raised Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $10.00 to $11.00 in a report on Friday, May 15th. Truist Financial boosted their price objective on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the company a "hold" rating in a research note on Monday. Finally, BMO Capital Markets upped their price objective on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the stock an "outperform" rating in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, Aveanna Healthcare has an average rating of "Moderate Buy" and an average target price of $12.89.

Institutional Trading of Aveanna Healthcare

A number of institutional investors have recently modified their holdings of the business. California State Teachers Retirement System grew its holdings in Aveanna Healthcare by 1,351.3% during the second quarter. California State Teachers Retirement System now owns 730,027 shares of the company's stock worth $6,256,000 after acquiring an additional 679,727 shares during the period. Braidwell LP lifted its holdings in Aveanna Healthcare by 39.1% in the second quarter. Braidwell LP now owns 3,065,106 shares of the company's stock valued at $26,268,000 after acquiring an additional 861,600 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Aveanna Healthcare by 17.6% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 96,956 shares of the company's stock worth $831,000 after purchasing an additional 14,492 shares in the last quarter. Littlejohn & Co. LLC purchased a new stake in shares of Aveanna Healthcare during the 2nd quarter worth $1,846,878,000. Finally, Corient Private Wealth LP acquired a new position in shares of Aveanna Healthcare during the 2nd quarter worth $176,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc NASDAQ: AVAH is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source